Toldi J - Search Results

1

Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs.

Fehér E, Szatmári I, Dudás T, Zalatnai A, Farkas T, Lőrinczi B, Fülöp F, Vécsei L, Toldi J. Fehér E, et al. Among authors: toldi j. Molecules. 2019 Sep 26;24(19):3502. doi: 10.3390/molecules24193502. Molecules. 2019. PMID: 31561643 Free PMC article.

2

Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.

Füvesi J, Somlai C, Németh H, Varga H, Kis Z, Farkas T, Károly N, Dobszay M, Penke Z, Penke B, Vécsei L, Toldi J. Füvesi J, et al. Among authors: toldi j. Pharmacol Biochem Behav. 2004 Jan;77(1):95-102. doi: 10.1016/j.pbb.2003.10.001. Pharmacol Biochem Behav. 2004. PMID: 14724046

3

The Janus-face kynurenic acid.

Rózsa E, Robotka H, Vécsei L, Toldi J. Rózsa E, et al. Among authors: toldi j. J Neural Transm (Vienna). 2008 Aug;115(8):1087-91. doi: 10.1007/s00702-008-0052-5. Epub 2008 Apr 30. J Neural Transm (Vienna). 2008. PMID: 18446262

4

The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.

Rozsa E, Robotka H, Nagy D, Farkas T, Sas K, Vecsei L, Toldi J. Rozsa E, et al. Among authors: toldi j. Brain Res Bull. 2008 Jul 30;76(5):474-9. doi: 10.1016/j.brainresbull.2007.12.001. Epub 2007 Dec 28. Brain Res Bull. 2008. PMID: 18534254

5

A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study.

Marosi M, Nagy D, Farkas T, Kis Z, Rózsa E, Robotka H, Fülöp F, Vécsei L, Toldi J. Marosi M, et al. Among authors: toldi j. J Neural Transm (Vienna). 2010 Feb;117(2):183-8. doi: 10.1007/s00702-009-0346-2. Epub 2009 Dec 2. J Neural Transm (Vienna). 2010. PMID: 19953278

6

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

Zádori D, Nyiri G, Szonyi A, Szatmári I, Fülöp F, Toldi J, Freund TF, Vécsei L, Klivényi P. Zádori D, et al. Among authors: toldi j. J Neural Transm (Vienna). 2011 Jun;118(6):865-75. doi: 10.1007/s00702-010-0573-6. Epub 2010 Dec 31. J Neural Transm (Vienna). 2011. PMID: 21194001

7

Time-course of kynurenic acid concentration in mouse serum following the administration of a novel kynurenic acid analog.

Zádori D, Ilisz I, Klivényi P, Szatmári I, Fülöp F, Toldi J, Vécsei L, Péter A. Zádori D, et al. Among authors: toldi j. J Pharm Biomed Anal. 2011 Jun 1;55(3):540-3. doi: 10.1016/j.jpba.2011.02.014. Epub 2011 Feb 17. J Pharm Biomed Anal. 2011. PMID: 21392919

8

Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia.

Gellért L, Fuzik J, Göblös A, Sárközi K, Marosi M, Kis Z, Farkas T, Szatmári I, Fülöp F, Vécsei L, Toldi J. Gellért L, et al. Among authors: toldi j. Eur J Pharmacol. 2011 Sep 30;667(1-3):182-7. doi: 10.1016/j.ejphar.2011.05.069. Epub 2011 Jun 12. Eur J Pharmacol. 2011. PMID: 21664350

9

Behavioural studies with a newly developed neuroprotective KYNA-amide.

Gellért L, Varga D, Ruszka M, Toldi J, Farkas T, Szatmári I, Fülöp F, Vécsei L, Kis Z. Gellért L, et al. Among authors: toldi j. J Neural Transm (Vienna). 2012 Feb;119(2):165-72. doi: 10.1007/s00702-011-0692-8. Epub 2011 Aug 5. J Neural Transm (Vienna). 2012. PMID: 21818601

10

Modifications on the carboxylic function of kynurenic acid.

Fülöp F, Szatmári I, Toldi J, Vécsei L. Fülöp F, et al. Among authors: toldi j. J Neural Transm (Vienna). 2012 Feb;119(2):109-14. doi: 10.1007/s00702-011-0721-7. Epub 2011 Oct 14. J Neural Transm (Vienna). 2012. PMID: 21997444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page